PHARMACEUTICAL COMPOSITION THAT IS ANTICANCER AND SUPPRESSES CANCER METASTASIS, CONTAINING, AS ACTIVE INGREDIENT, FUSION PEPTIDE SIMULTANEOUSLY TARGETING CANCER CELL AND TUMOR ASSOCIATED MACROPHAGE

摘要

The present invention relates to a pharmaceutical composition that is anticancer and suppresses cancer metastasis, containing a fusion peptide as an active ingredient. More specifically, the present invention relates to a pharmaceutical composition exhibiting an excellent anticancer effect and a cancer metastasis suppression effect by simultaneously targeting a cancer cell and a tumor associated macrophage (TAM) in which IL-4 receptors are overexpressed. The pharmaceutical composition of the present invention simultaneously targets a tumor cell and a TAM and kills the cells, thereby simultaneously having an anticancer effect and a cancer metastasis suppression effect. In addition, the fusion peptide of the present invention decreases side effects of conventional anticancer effects and exhibits anticancer and cancer metastasis suppression effects, when co-administered with conventional anticancer drugs.